– Allelica, Inc. collaborates with Thermo Fisher Scientific to provide end-to-end solutions for genomics research customers
– Polygenic risk scores (PRS) are gaining interest in genetic research and medical communities for disease risk prediction and patient stratification
– Allelica offers a wide selection of PRS validated in multiple ancestries, allowing implementation in diverse populations
– Through the collaboration, clinical researchers now have access to off-the-shelf workflows including everything needed to create and implement PRS
– The collaboration aims to streamline data analysis and help researchers focus on translating genetic insights into impactful actions
– Allelica’s software allows for new PRS development and validation on diverse datasets
– Thermo Fisher’s Axiom™ Human Genotyping Microarrays are utilized in the collaboration for genomic research
– The collaboration aims to enable significant advances in precision medicine and personalized treatment strategies
– Allelica specializes in secure and scalable solutions for polygenic risk score analysis
– The collaboration aims to improve disease outcomes in the future by translating research into clinical practice.